SCD and metabolic dysfunction-associated steatotic liver disease: Finally, we observed that interventional pharmacologic approaches, such as improving NAFLD by clofibrate, not only reverted the liver phenotype but also significantly affected the hepatic Scd1 transcriptional activity and protein dimerization.